Lower the cost of prescription drugs.

lowering the cost of prescription drugs

He commits to lowering prescription drug costs.

Meet Gus – Bilirakis For Congress
campaign · campaign_site · model gpt-5.4-mini

PBM reforms to increase transparency, ensure fair pricing, and lower out-of-pocket costs for patients.

Bilirakis said he championed pharmacy benefit manager reforms aimed at lowering patient drug costs.

Bilirakis Touts Policy and Appropriations Wins in House Spending Package | Congressman Gus Bilirakis
primary · press_release · model gpt-5.4-mini

Cutting Copays Act – Eliminates copays for generic medications under Medicare Part D’s Low Income Subsidy Program, lowering costs for vulnerable seniors.

The release cites support for eliminating Medicare copays for generic medications.

Bilirakis Touts Policy and Appropriations Wins in House Spending Package | Congressman Gus Bilirakis
primary · press_release · model gpt-5.4-mini

The committee advanced bills aimed to lower prescription drug prices, with Republicans including Gus Bilirakis supporting measures that promote competition, lower out-of-pocket costs, and increase transparency.

Shows Bilirakis actively supporting legislative efforts to lower prescription drug costs, but this is not a completed delivery claim.

unresolved same_term A for effort

What They're Saying: E&C Republicans Help Advance Bipartisan Drug Pricing Bills | House Energy and Commerce Committee
secondary · model gpt-5.4-mini · confidence 71%

Bilirakis said the bill would help seniors access cost-saving tools like the out-of-pocket prescription drug spending cap included in the Inflation Reduction Act, and would help them learn how to lower costs and understand Medicare options.

Concrete action on prescription-drug affordability, but it is an introduction/assistive measure rather than proof the broader promise was delivered.

partial same_term A for effort

Bilirakis and Colleagues Introduce Bill to Protect Low-Income Seniors’ Access to Unbiased Medicare Assistance
secondary · model gpt-5.4-mini · confidence 83%

The office says Bilirakis helped secure FY2026 appropriations-package policy wins including Pharmacy Benefit Manager reforms; the release states PBMs obscure pricing, drive up medication costs, and that Bilirakis championed reforms to increase transparency, ensure fair pricing, and lower out-of-pocket costs for patients.

Strong evidence of active, concrete steps toward lower drug prices via PBM reform, but not a final, universal delivery of the claim.

partial same_term A for effort

Bilirakis Touts Policy and Appropriations Wins in House Spending Package
secondary · model gpt-5.4-mini · confidence 88%

The House Energy and Commerce Health Subcommittee held a hearing focused on the prescription drug supply chain and lower costs for American patients.

Confirms ongoing committee-level work on drug affordability during the lookback period, but not delivery on the promise itself.

unresolved same_term A for effort

Health Subcommittee Examines Prescription Drug Supply Chain to Lower Costs for American Patients
secondary · model gpt-5.4-mini · confidence 74%

The committee says President Trump signed into law PBM reforms in the Consolidated Appropriations Act of 2026, including delinking Medicare Part D drug prices from PBM compensation and requiring rebates be passed through to plan sponsors.

This is the strongest recent evidence that a major prescription-drug-cost-reduction policy was enacted, and Bilirakis serves on the Energy and Commerce Committee; however, the source does not specifically attribute enactment to Bilirakis alone.

delivered same_term

Chairman Guthrie Celebrates Long-Awaited PBM Reform Being Signed into Law
secondary · model gpt-5.4-mini · confidence 79%